Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Norepinephrine in Hemorrhagic Shock Resuscitation
NCT06311903Recruiting
- Sponsor
- Tanta University
- Start
- Dec 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of norepinephrine in hemorrhagic shock (2 arms), sponsored by Tanta University. Primary endpoint: 24 hours mortality. Started Dec 2023; status: recruiting.
02
Drugs
norepinephrine
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT06311903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06311903.